68Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients

[1] Sooriakumaran P(2014)Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes BMJ 348 g1502-218

[2] Nyberg T(2012)MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy World J Urol 30 213-1386

[3] Akre O(2013)Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer J Urol 190 1380-929

[4] Haendler L(1999)Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy Int J Radiat Oncol Biol Phys 44 921-620

[5] Heus I(2011)Parameters favorable to intraprostatic radiation dose escalation in men with localized prostate cancer Int J Radiat Oncol Biol Phys 80 614-212

[6] Olsson M(2013)Helical tomotherapy and intensity modulated proton therapy in the treatment of dominant intraprostatic lesion: a treatment planning comparison Radiother Oncol 107 207-960

[7] Roethke M(2014)Effect on therapeutic ratio of planning a boosted radiotherapy dose to the dominant intraprostatic tumour lesion within the prostate based on multifunctional MR parameters Br J Radiol 87 20130813-159

[8] Anastasiadis AG(2013)Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer Eur Urol 64 953-S35

[9] Lichy M(2014)[(11)C]Choline PET/CT impacts treatment decision making in patients with prostate cancer referred for radiotherapy Clin Genitourin Cancer 12 155-697

[10] Werner M(2013)Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer Eur J Nucl Med Mol Imaging 40 S28-864

[1] Sooriakumaran P(2014)Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes BMJ 348 g1502-218

[2] Nyberg T(2012)MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy World J Urol 30 213-1386

[3] Akre O(2013)Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer J Urol 190 1380-929

[4] Haendler L(1999)Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy Int J Radiat Oncol Biol Phys 44 921-620

[5] Heus I(2011)Parameters favorable to intraprostatic radiation dose escalation in men with localized prostate cancer Int J Radiat Oncol Biol Phys 80 614-212

[6] Olsson M(2013)Helical tomotherapy and intensity modulated proton therapy in the treatment of dominant intraprostatic lesion: a treatment planning comparison Radiother Oncol 107 207-960

[7] Roethke M(2014)Effect on therapeutic ratio of planning a boosted radiotherapy dose to the dominant intraprostatic tumour lesion within the prostate based on multifunctional MR parameters Br J Radiol 87 20130813-159

[8] Anastasiadis AG(2013)Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer Eur Urol 64 953-S35

[9] Lichy M(2014)[(11)C]Choline PET/CT impacts treatment decision making in patients with prostate cancer referred for radiotherapy Clin Genitourin Cancer 12 155-697

[10] Werner M(2013)Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer Eur J Nucl Med Mol Imaging 40 S28-864